Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: HU, FCF
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
ABNT
WILLRICH, Maria Alice Vieira et al. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2010APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R. de, Maureira, A. D. C., et al. (2010). CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo.NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.[citado 2024 nov. 10 ]Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.[citado 2024 nov. 10 ]